These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

295 related articles for article (PubMed ID: 32745511)

  • 1. Host antiviral protein IFITM2 restricts pseudorabies virus replication.
    Xie J; Bi Y; Xu S; Han Y; Idris A; Zhang H; Li X; Bai J; Zhang Y; Feng R
    Virus Res; 2020 Oct; 287():198105. PubMed ID: 32745511
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pseudorabies virus usurps non-muscle myosin heavy chain IIA to dampen viral DNA recognition by cGAS for antagonism of host antiviral innate immunity.
    Liu Y; Qin Y; Yang B; Zheng H; Qiao S; Luo Z; Li R
    J Virol; 2024 May; 98(5):e0048324. PubMed ID: 38639486
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Porcine ISG15 modulates the antiviral response during pseudorabies virus replication.
    Liu H; Li S; Yang X; Wang X; Li Y; Wang C; Chen L; Chang H
    Gene; 2018 Dec; 679():212-218. PubMed ID: 30201339
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cholesterol 25-hydroxylase acts as a host restriction factor on pseudorabies virus replication.
    Wang J; Zeng L; Zhang L; Guo ZZ; Lu SF; Ming SL; Li GL; Wan B; Tian KG; Yang GY; Chu BB
    J Gen Virol; 2017 Jun; 98(6):1467-1476. PubMed ID: 28631596
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Porcine IFITM1 is a host restriction factor that inhibits pseudorabies virus infection.
    Wang J; Wang CF; Ming SL; Li GL; Zeng L; Wang MD; Su BQ; Wang Q; Yang GY; Chu BB
    Int J Biol Macromol; 2020 May; 151():1181-1193. PubMed ID: 31743714
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cathelicidin CATH-B1 Inhibits Pseudorabies Virus Infection via Direct Interaction and TLR4/JNK/IRF3-Mediated Interferon Activation.
    Ye C; Wan C; Chen J; Li G; Li Y; Wang Y; Tao Q; Peng L; Fang R
    J Virol; 2023 Jul; 97(7):e0070623. PubMed ID: 37314341
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long Noncoding RNA IFITM4P Regulates Host Antiviral Responses by Acting as a Competing Endogenous RNA.
    Xiao M; Chen Y; Wang S; Liu S; Rai KR; Chen B; Li F; Li Y; Maarouf M; Chen JL
    J Virol; 2021 Oct; 95(21):e0027721. PubMed ID: 34287042
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of PARP1 Dampens Pseudorabies Virus Infection through DNA Damage-Induced Antiviral Innate Immunity.
    Li GL; Ding GX; Zeng L; Ming SL; Fu PF; Wang Q; Yang GY; Wang J; Chu BB
    J Virol; 2021 Jul; 95(16):e0076021. PubMed ID: 34037418
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interferon-Induced Transmembrane Proteins Inhibit Infection by the Kaposi's Sarcoma-Associated Herpesvirus and the Related Rhesus Monkey Rhadinovirus in a Cell-Specific Manner.
    Hörnich BF; Großkopf AK; Dcosta CJ; Schlagowski S; Hahn AS
    mBio; 2021 Dec; 12(6):e0211321. PubMed ID: 34933450
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Role of IFITM Proteins in Tick-Borne Encephalitis Virus Infection.
    Chmielewska AM; Gómez-Herranz M; Gach P; Nekulova M; Bagnucka MA; Lipińska AD; Rychłowski M; Hoffmann W; Król E; Vojtesek B; Sloan RD; Bieńkowska-Szewczyk K; Hupp T; Ball K
    J Virol; 2022 Jan; 96(1):e0113021. PubMed ID: 34613785
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IFITM Proteins That Restrict the Early Stages of Respiratory Virus Infection Do Not Influence Late-Stage Replication.
    Meischel T; Fritzlar S; Villalon-Letelier F; Tessema MB; Brooks AG; Reading PC; Londrigan SL
    J Virol; 2021 Sep; 95(20):e0083721. PubMed ID: 34319159
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pseudorabies virus tegument protein US2 antagonizes antiviral innate immunity by targeting cGAS-STING signaling pathway.
    Kong Z; Chen X; Gong L; Wang L; Zhang Y; Guan K; Yao W; Kang Y; Lu X; Zhang Y; Du Y; Sun A; Zhuang G; Zhao J; Wan B; Zhang G
    Front Immunol; 2024; 15():1403070. PubMed ID: 39015575
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TMEM41B Is an Interferon-Stimulated Gene That Promotes Pseudorabies Virus Replication.
    Li XQ; Zeng L; Liang DG; Qi YL; Yang GY; Zhong K; Chu BB; Wang J
    J Virol; 2023 Jun; 97(6):e0041223. PubMed ID: 37255475
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Host Restriction Factor Interferon-Inducible Transmembrane Protein 3 Inhibits Vaccinia Virus Infection.
    Li C; Du S; Tian M; Wang Y; Bai J; Tan P; Liu W; Yin R; Wang M; Jiang Y; Li Y; Zhu N; Zhu Y; Li T; Wu S; Jin N; He F
    Front Immunol; 2018; 9():228. PubMed ID: 29503647
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Tug of War: Pseudorabies Virus and Host Antiviral Innate Immunity.
    Ye G; Liu H; Zhou Q; Liu X; Huang L; Weng C
    Viruses; 2022 Mar; 14(3):. PubMed ID: 35336954
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of pseudorabies virus replication via upregulated interferon response by targeting 7-dehydrocholesterol reductase.
    Ma Z; Guo L; Pan M; Jiang C; Liu D; Gao Y; Bai J; Jiang P; Liu X
    Vet Microbiol; 2024 Mar; 290():110000. PubMed ID: 38278042
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of p53 in pseudorabies virus replication, pathogenicity, and host immune responses.
    Li X; Zhang W; Liu Y; Xie J; Hu C; Wang X
    Vet Res; 2019 Feb; 50(1):9. PubMed ID: 30717799
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pseudorabies Virus EP0 Antagonizes the Type I Interferon Response via Inhibiting IRF9 Transcription.
    Wang M; Liu Y; Qin C; Lang Y; Xu A; Yu C; Zhao Z; Zhang R; Yang J; Tang J
    J Virol; 2022 Jul; 96(13):e0217121. PubMed ID: 35708311
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pseudorabies virus-induced expression and antiviral activity of type I or type III interferon depend on the type of infected epithelial cell.
    Yin Y; Ma J; Van Waesberghe C; Devriendt B; Favoreel HW
    Front Immunol; 2022; 13():1016982. PubMed ID: 36405751
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Polybasic Cleavage Site in SARS-CoV-2 Spike Modulates Viral Sensitivity to Type I Interferon and IFITM2.
    Winstone H; Lista MJ; Reid AC; Bouton C; Pickering S; Galao RP; Kerridge C; Doores KJ; Swanson CM; Neil SJD
    J Virol; 2021 Apr; 95(9):. PubMed ID: 33563656
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.